Human adipocyte cell populations and methods for identifying modulators of same
AssigneeAdipoGenix, Inc.
InventorsMichael Stevenson, James Kirkland
Life of this patent
Estimating the term…
Abstract
The invention features methods of obtaining high-yield, essentially pure human predipocyte cultures. Cultures obtained according to the instant methodology are also featured as are methods of identifying adipogenic modulatory agents, e.g., high-throughput screening assays.
Claims56
A method for identifying a fat modulatory compound, comprising:
- (a) obtaining a high-yield, essentially pure human preadipocyte population;
- (b) culturing said preadipocyte population under conditions sufficient to induce differentiation;
- (c) contacting said population with a test compound at least 1-3 days following initial culture in the differentiation medium;
- (d) maintaining said population in the presence of said test compound;
- and
- (e) assaying the population for fatty-acid uptake or accumulation, a detectable fluctuation in which indicates that the test compound is a fat modulatory compound.
A method for identifying a fat modulatory compound, comprising:
- (a) obtaining a high-yield, essentially pure human preadipocyte population;
- (b) culturing said preadipocyte population under conditions sufficient to induce differentiation;
- (c) contacting said population with a test compound at least 6-10 days following initial culture in the differentiation medium;
- (d) maintaining said population in the presence of said test compound;
- and
- (e) assaying the population for fatty-acid uptake or accumulation, a detectable fluctuation in which indicates that the test compound is a fat modulatory compound.
A method for identifying a potential weight loss or anti-obesity agent, comprising:
- (a) obtaining a high-yield, essentially pure human preadipocyte population;
- (b) culturing said preadipocyte population under conditions sufficient to induce differentiation;
- (c) contacting said population with a test compound at least 1-3 days following initial culture in the differentiation medium;
- (d) maintaining said population in the presence of said test compound;
- and
- (e) assaying the population for fatty-acid uptake or accumulation, a detectable inhibition of which identifies the test compound as a potential weight loss or anti-obesity agent.
A method for identifying a potential weight loss or anti-obesity agent, comprising:
- (a) obtaining a high-yield, essentially pure human preadipocyte population;
- (b) culturing said preadipocyte population under conditions sufficient to induce differentiation;
- (c) contacting said population with a test compound at least 6-10 days following initial culture in the differentiation medium;
- (d) maintaining said population in the presence of said test compound;
- and
- (e) assaying the population for fatty-acid uptake or accumulation, a detectable inhibition of which identifies the test compound as a potential weight loss or anti-obesity agent.
A method for identifying a target for an agent modulating weight gain comprising:
- identifying a compound that inhibits differentiation of preadipocytes to adipocytes in the absence of substantial toxicity to said preadipocytes;
- and determining the presence or absence of an alteration in lipogenesis, lipolysis, and oxidation in the presence of said compound, wherein an alteration signifies said target.
A method for identifying a fat depot-specific inhibitor of human preadipocyte differentiation, comprising:
- (a) identifying an inhibitor of human preadipocyte differentiation in a preadipocyte population derived from a first depot;
- and
- (b) comparing the efficacy of said inhibitor in a preadipocyte population from a second depot, such that a fat depot-specific inhibitor of human preadipocyte differentiation is identified.
A cell population comprising human preadipocytes, wherein said population is essentially pure.
A human preadipocyte cell strain which maintains differentiative capacity over at least 8 passages.
A human preadipocyte cell strain which maintains differentiative capacity over at least 25 passages.
A high-yield process for obtaining a human preadipocyte cell population which is essentially pure, comprising:
- (a) isolating a mixed cell population from said fat tissue sample under conditions favoring a high preadipocyte yield;
- and
- (b) removing contaminants from said mixed cell population, such that the essentially pure human preadipocyte cell population is obtained.
A method of obtaining a highly-differentiated human adipocyte cell culture, comprising:
- (a) obtaining a high-yield, essentially pure population of human preadipocytes;
- (b) plating said preadipocytes at a density sufficient to ensure essentially 100% confluence upon adherence to the cell culture dish or plate;
- (c) maintaining said preadipocytes in a serum-free differentiation medium such that a highly-differentiated human adipocyte cell culture is obtained.
A method of obtaining a high-yield, essentially pure culture of human preadipocytes comprising;
- (a) enzymatically dissociating a mixed-cell population from human fat tissue in serum-free, bovine serum (BSA)-containing isolation media;
- (b) isolating the mixed-cell population from non-cell contaminants using gauze filters;
- (c) treating the mixed-cell population with an erythrocyte lysis buffer prior to plating the cell population;
- and
- (d) selectively trypsinizing the cell population and replating in a serum-free differentiation medium at a density sufficient to insure confluence.
Dependencies are inferred from the claim text.